Evolving existing drug classes to meet the challenges of unmet medical needs: navigating regulatory perspectives

“Evolving existing drug classes to meet the challenge of unmet medical needs: navigating regulatory perspectives “

Mark Jones, PhD, Head of Project Management at Basilea Pharmaceutica joined us for World Anti-Microbial Resistance Congress USA 2015 to discuss ‘navigating regulatory perspectives ‘.

In this presentation, learn about navigating regulatory perspectives in the context of the unmet medical need for new antifungals .

Download the presentation to understand more about:

  • Where will our new antifungals come from?
  • The net present value (NPV) of a typical antimicrobial
  • Incentives for making drug development more attractive

…and much more!

Get your copy here!

To learn more about regulatory perspectives and unmet medical needs for new antimicrobials , join us at World Anti-Microbial Resistance Congress USA 2016 held September 8-9 in Washington, DC.

Attend World Anti-Microbial Resistance USA 2016

Leave a Reply

Your email address will not be published. Required fields are marked *